LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | AZD 5438 | 1.11 | uM | LJP6 | 2 | J03 | 72 | hr | 962 | 645 | 10740 | 0.0601 | -0.1086 |
MCF 10A | AZD 5438 | 1.11 | uM | LJP6 | 3 | J03 | 72 | hr | 962 | 793 | 10641 | 0.0745 | -0.0542 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 1 | J02 | 72 | hr | 962 | 261 | 10693 | 0.0244 | -0.3131 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 2 | J02 | 72 | hr | 962 | 234 | 10740 | 0.0218 | -0.3338 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 3 | J02 | 72 | hr | 962 | 287 | 10641 | 0.0270 | -0.2945 |
MCF 10A | AZD 5438 | 10 | uM | LJP6 | 1 | J01 | 72 | hr | 962 | 329 | 10693 | 0.0308 | -0.2657 |
MCF 10A | AZD 5438 | 10 | uM | LJP6 | 2 | J01 | 72 | hr | 962 | 288 | 10740 | 0.0268 | -0.2929 |
MCF 10A | AZD 5438 | 10 | uM | LJP6 | 3 | J01 | 72 | hr | 962 | 383 | 10641 | 0.0360 | -0.2333 |
MCF 10A | Pelitinib | 0.04 | uM | LJP5 | 1 | I18 | 72 | hr | 962 | 2795 | 10714 | 0.2609 | 0.3589 |
MCF 10A | Pelitinib | 0.04 | uM | LJP5 | 2 | I18 | 72 | hr | 962 | 2946 | 10507 | 0.2804 | 0.3833 |
MCF 10A | Pelitinib | 0.04 | uM | LJP5 | 3 | I18 | 72 | hr | 962 | 3753 | 10315 | 0.3638 | 0.4884 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 1 | I17 | 72 | hr | 962 | 1460 | 10714 | 0.1363 | 0.1274 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 2 | I17 | 72 | hr | 962 | 1367 | 10507 | 0.1301 | 0.1072 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 3 | I17 | 72 | hr | 962 | 1375 | 10315 | 0.1333 | 0.1100 |
MCF 10A | Pelitinib | 0.37 | uM | LJP5 | 1 | I16 | 72 | hr | 962 | 1334 | 10714 | 0.1245 | 0.0985 |
MCF 10A | Pelitinib | 0.37 | uM | LJP5 | 2 | I16 | 72 | hr | 962 | 1495 | 10507 | 0.1423 | 0.1363 |
MCF 10A | Pelitinib | 0.37 | uM | LJP5 | 3 | I16 | 72 | hr | 962 | 1191 | 10315 | 0.1155 | 0.0643 |
MCF 10A | Pelitinib | 1.11 | uM | LJP5 | 1 | I15 | 72 | hr | 962 | 1377 | 10714 | 0.1285 | 0.1086 |
MCF 10A | Pelitinib | 1.11 | uM | LJP5 | 2 | I15 | 72 | hr | 962 | 1492 | 10507 | 0.1420 | 0.1356 |
MCF 10A | Pelitinib | 1.11 | uM | LJP5 | 3 | I15 | 72 | hr | 962 | 1348 | 10315 | 0.1307 | 0.1035 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 1 | I14 | 72 | hr | 962 | 1476 | 10714 | 0.1378 | 0.1310 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 2 | I14 | 72 | hr | 962 | 1510 | 10507 | 0.1437 | 0.1396 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 3 | I14 | 72 | hr | 962 | 1320 | 10315 | 0.1280 | 0.0968 |
MCF 10A | Pelitinib | 10 | uM | LJP5 | 1 | I13 | 72 | hr | 962 | 755 | 10714 | 0.0705 | -0.0674 |
MCF 10A | Pelitinib | 10 | uM | LJP5 | 2 | I13 | 72 | hr | 962 | 715 | 10507 | 0.0680 | -0.0825 |